PBMs readying their defenses against pharmaceutical companies
Published Updated
5 Min Read
More From Employee Benefit News
With healthcare costs jumping 9%, employers are shifting strategy
Employers face another steep rise in healthcare expenses in 2027, prompting a closer look at GLP-1 coverage, pharmacy spending and high-cost conditions.
Employers face a new GLP-1 question: Are the drugs worth it?
As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.
At this childcare center, time off is mandated to ensure employees unplug
At parent support company Haven, CEO Britt Riley offers benefits that make employees feel taken care of.
What Trump’s ‘Great Healthcare Plan’ means for drug costs and price transparency
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
Healthcare costs are forcing employers to reconsider their benefits strategy
Employers are under pressure to keep benefits competitive while controlling costs, driving new scrutiny of PBMs, hospital prices and GLP-1 coverage for 2027.
